LFST Q3 Deep Dive: Productivity Initiatives and Tech Investment Drive Behavioral Health Growth

Behavioral health company LifeStance Health (NASDAQ:LFST) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 16.3% year on year to $363.8 million. The company expects next quarter’s revenue to be around $378 million, close to analysts’ estimates. Its GAAP profit of $0 per share was $0.01 above analysts’ consensus estimates. Is now the time to buy LFST? Find out in our full research report (it’s free for active Edge members). LifeStance Health Group (LFST) Q3 CY2025 Highlights: Revenue: ...